Cargando…
Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Predicting worsening heart failure (WHF) events in chronic heart failure (HF) patients is important to avoid hospitalizations. In patients implanted with cardiac implantable electronic devices (CIEDs) remote monitoring may help to...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206656/ http://dx.doi.org/10.1093/europace/euad122.548 |
_version_ | 1785046278700269568 |
---|---|
author | Ziacchi, M Biffi, M Mauro, E Molon, G Costa, A Dell' Aquila, A Viscardi, L Botto, G Casale, M C Viscusi, M Brasca, F Santoro, A Curcio, A Manzo, M Boriani, G |
author_facet | Ziacchi, M Biffi, M Mauro, E Molon, G Costa, A Dell' Aquila, A Viscardi, L Botto, G Casale, M C Viscusi, M Brasca, F Santoro, A Curcio, A Manzo, M Boriani, G |
author_sort | Ziacchi, M |
collection | PubMed |
description | FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Predicting worsening heart failure (WHF) events in chronic heart failure (HF) patients is important to avoid hospitalizations. In patients implanted with cardiac implantable electronic devices (CIEDs) remote monitoring may help to identify patients at risk of WHF thanks to the ability to monitor physiological parameters that may change before WHF. However, clinicians need to know patient HF-related signs, symptoms and therapy non-compliance to determine type and time of necessary interventions. A patient Smartphone Application (App) may be an ideal option to remotely collect this information from patients and help clinicians in the decision-making process. PURPOSE: to assess the penetration of App technology in a large real-world HF population and to evaluate patient willingness and compliance to use a HF-dedicated App to weekly send a diary on HF signs, symptoms and therapy compliance to the cardiologist. METHODS: From January 2021 to July 2022, 10 Italian hospitals in the framework of the One Hospital ClinicalService project designed a questionnaire on the use of App technology and submitted it to their HF patients with CIED during scheduled in-hospital follow-up. If the patient or his caregiver was able and willing to use Apps, the HF-dedicated App was activated on his smartphone. Compliance in using the App (= percentage of weeks in a year with at list an App diary received by all patients) was evaluated for patients who have received it for at least one year. RESULTS: 495 HF patients with CIED (age 67±13 years, 79% males, 26% NYHA III-IV, LVEF 35±11%, 60% with 3-chamber CIED, 43% with high school qualification) completed the questionnaire. Out of them, 80% have access to App technology, directly or through a caregiver; ≥62% can do all high-level activities (APP installation, email, web browsing) and 21% has already used Health Apps; 73% is willing to weekly send a diary using the App. 311 patients (63% of respondents) downloaded the HF-dedicated App on their or caregiver’s smartphone. They were younger and with higher school qualification than those not receiving the App. No other difference in baseline characteristics was seen. 138 patients have received the App for at least 1 year. Their compliance decreased during time, from 60% (weeks 1-13) to 42% (weeks 40-52; p <.001). Patients aging ≥ 60 years had a higher mean yearly compliance (53%) than younger patients (42%; p <.001; Fig. 1). Hospitals with dedicated staff to remote monitoring achieved a higher mean yearly patient compliance (64%) than other sites (33%, p <.001). CONCLUSION: In a large real-world HF population with CIED patients, the penetration of Smartphone technology was high and > 60-year-old patients had higher compliance to the use of a new HF-dedicated App compared to younger patients. The use of Smartphone App technology to collect WHF sign/symptoms is feasible and may improve remote management of HF patients. [Figure: see text] |
format | Online Article Text |
id | pubmed-10206656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102066562023-05-25 Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices Ziacchi, M Biffi, M Mauro, E Molon, G Costa, A Dell' Aquila, A Viscardi, L Botto, G Casale, M C Viscusi, M Brasca, F Santoro, A Curcio, A Manzo, M Boriani, G Europace 38.7 - Remote Patient Monitoring and Telehealth FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Predicting worsening heart failure (WHF) events in chronic heart failure (HF) patients is important to avoid hospitalizations. In patients implanted with cardiac implantable electronic devices (CIEDs) remote monitoring may help to identify patients at risk of WHF thanks to the ability to monitor physiological parameters that may change before WHF. However, clinicians need to know patient HF-related signs, symptoms and therapy non-compliance to determine type and time of necessary interventions. A patient Smartphone Application (App) may be an ideal option to remotely collect this information from patients and help clinicians in the decision-making process. PURPOSE: to assess the penetration of App technology in a large real-world HF population and to evaluate patient willingness and compliance to use a HF-dedicated App to weekly send a diary on HF signs, symptoms and therapy compliance to the cardiologist. METHODS: From January 2021 to July 2022, 10 Italian hospitals in the framework of the One Hospital ClinicalService project designed a questionnaire on the use of App technology and submitted it to their HF patients with CIED during scheduled in-hospital follow-up. If the patient or his caregiver was able and willing to use Apps, the HF-dedicated App was activated on his smartphone. Compliance in using the App (= percentage of weeks in a year with at list an App diary received by all patients) was evaluated for patients who have received it for at least one year. RESULTS: 495 HF patients with CIED (age 67±13 years, 79% males, 26% NYHA III-IV, LVEF 35±11%, 60% with 3-chamber CIED, 43% with high school qualification) completed the questionnaire. Out of them, 80% have access to App technology, directly or through a caregiver; ≥62% can do all high-level activities (APP installation, email, web browsing) and 21% has already used Health Apps; 73% is willing to weekly send a diary using the App. 311 patients (63% of respondents) downloaded the HF-dedicated App on their or caregiver’s smartphone. They were younger and with higher school qualification than those not receiving the App. No other difference in baseline characteristics was seen. 138 patients have received the App for at least 1 year. Their compliance decreased during time, from 60% (weeks 1-13) to 42% (weeks 40-52; p <.001). Patients aging ≥ 60 years had a higher mean yearly compliance (53%) than younger patients (42%; p <.001; Fig. 1). Hospitals with dedicated staff to remote monitoring achieved a higher mean yearly patient compliance (64%) than other sites (33%, p <.001). CONCLUSION: In a large real-world HF population with CIED patients, the penetration of Smartphone technology was high and > 60-year-old patients had higher compliance to the use of a new HF-dedicated App compared to younger patients. The use of Smartphone App technology to collect WHF sign/symptoms is feasible and may improve remote management of HF patients. [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10206656/ http://dx.doi.org/10.1093/europace/euad122.548 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | 38.7 - Remote Patient Monitoring and Telehealth Ziacchi, M Biffi, M Mauro, E Molon, G Costa, A Dell' Aquila, A Viscardi, L Botto, G Casale, M C Viscusi, M Brasca, F Santoro, A Curcio, A Manzo, M Boriani, G Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
title | Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
title_full | Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
title_fullStr | Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
title_full_unstemmed | Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
title_short | Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
title_sort | feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices |
topic | 38.7 - Remote Patient Monitoring and Telehealth |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206656/ http://dx.doi.org/10.1093/europace/euad122.548 |
work_keys_str_mv | AT ziacchim feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT biffim feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT mauroe feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT molong feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT costaa feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT dellaquilaa feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT viscardil feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT bottog feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT casalemc feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT viscusim feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT brascaf feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT santoroa feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT curcioa feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT manzom feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices AT borianig feasibilityofusingsmartphoneapptechnologyintheremotemanagementofheartfailurepatientswithcardiacimplantableelectronicdevices |